• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾衰竭风险方程和中性粒细胞明胶酶相关脂质运载蛋白对中国人群慢性肾脏病进展的预测价值——一项回顾性研究

Predictive Value of Kidney Failure Risk Equation and Neutrophil Gelatinase-Associated Lipocalin for Chronic Kidney Disease Progression in Chinese Population - A Retrospective Study.

作者信息

Shi Liu, Liao Youxin, Chen Yue

机构信息

Department of Critical Care Medicine, Jiangjin Central Hospital, Chongqing, 402260, People's Republic of China.

Department of Medical Administration, Jiangjin Central Hospital, Chongqing, 402260, People's Republic of China.

出版信息

Int J Gen Med. 2024 Dec 30;17:6557-6565. doi: 10.2147/IJGM.S497268. eCollection 2024.

DOI:10.2147/IJGM.S497268
PMID:39759891
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11697685/
Abstract

OBJECTIVE

To analyze the independent associations of the Kidney Failure Risk Equation (KFRE) and neutrophil gelatinase-associated lipocalin (NGAL) with end-stage renal disease (ESRD) among patients with chronic kidney disease (CKD) stages 3-5 in China and evaluate their predictive values for ESRD.

PATIENTS AND METHODS

A total of 716 patients with CKD stages 3-5 at the time of the initial renal medicine referral were retrospectively enrolled, and the study outcome was the observed incidence of ESRD at 2 years after the initial referral. Baseline characteristics were collected, and relevant laboratory indexes, including neutrophil gelatinase-associated lipocalin (NGAL), were detected. The binary regression model was used to analyze the independent associations, and the receiver operating characteristic (ROC) curve was used to assess the predictive values.

RESULTS

The 2-year incidence of ESRD was 20.5% (147/716). The 4-variable KFRE, 8-variable KFRE and NGAL were independently associated with ESRD after adjusting for potential confounding factors. The AUCs of the 4-variable KFRE, 8-variable KFRE and NGAL for predicting ESRD among patients with CKD stages 3-5 were 0.711 [standard error (): 0.026, 95% confidence interval (): 0.662-0.761], 0.725 (: 0.025, 95% : 0.677-0.774) and 0.736 (: 0.024, 95% : 0.686-0.785), respectively. The AUC of the 4-variable KFRE plus NGAL was significantly higher than those of the 4-variable KFRE and NGAL alone (0.900 vs 0.711, = 6.297, < 0.001; 0.900 vs 0.736, = 5.795, < 0.001), and the AUC of the 8-variable KFRE plus NGAL was also significantly higher than those of the 8-variable KFRE and NGAL alone (0.911 vs 0.725, = 6.491, < 0.001; 0.911 vs 0.736, = 6.298, < 0.001).

CONCLUSION

The KFRE was able to independently predict progression of CKD stage 3-5 to ESRD in Chinese population. The addition of NGAL to the KFRE was able to elevate the predictive value when applied in predicting 2-year ESRD.

摘要

目的

分析在中国慢性肾脏病(CKD)3 - 5期患者中,肾衰竭风险方程(KFRE)和中性粒细胞明胶酶相关脂质运载蛋白(NGAL)与终末期肾病(ESRD)的独立相关性,并评估它们对ESRD的预测价值。

患者与方法

回顾性纳入716例初次肾内科转诊时处于CKD 3 - 5期的患者,研究结局为初次转诊后2年观察到的ESRD发病率。收集基线特征,并检测包括中性粒细胞明胶酶相关脂质运载蛋白(NGAL)在内的相关实验室指标。采用二元回归模型分析独立相关性,采用受试者工作特征(ROC)曲线评估预测价值。

结果

ESRD的2年发病率为20.5%(147/716)。校正潜在混杂因素后,4变量KFRE、8变量KFRE和NGAL与ESRD独立相关。CKD 3 - 5期患者中,4变量KFRE、8变量KFRE和NGAL预测ESRD的曲线下面积(AUC)分别为0.711[标准误(SE):0.026,95%置信区间(CI):0.662 - 0.761]、0.725(SE:0.025,95%CI:0.677 - 0.774)和0.736(SE:0.024,95%CI:0.686 - 0.785)。4变量KFRE加NGAL的AUC显著高于单独的4变量KFRE和NGAL(0.900对0.711,Z = 6.297,P < 0.001;0.900对0.736,Z = 5.795,P < 0.001),8变量KFRE加NGAL的AUC也显著高于单独的8变量KFRE和NGAL(0.911对0.725,Z = 6.491,P < 0.001;0.911对0.736,Z = 6.298,P < 0.001)。

结论

KFRE能够独立预测中国人群中CKD 3 - 5期进展至ESRD的情况。在预测2年ESRD时,将NGAL加入KFRE能够提高预测价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23e0/11697685/196838df523c/IJGM-17-6557-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23e0/11697685/196838df523c/IJGM-17-6557-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/23e0/11697685/196838df523c/IJGM-17-6557-g0001.jpg

相似文献

1
Predictive Value of Kidney Failure Risk Equation and Neutrophil Gelatinase-Associated Lipocalin for Chronic Kidney Disease Progression in Chinese Population - A Retrospective Study.肾衰竭风险方程和中性粒细胞明胶酶相关脂质运载蛋白对中国人群慢性肾脏病进展的预测价值——一项回顾性研究
Int J Gen Med. 2024 Dec 30;17:6557-6565. doi: 10.2147/IJGM.S497268. eCollection 2024.
2
Evaluation of serum neutrophil gelatinase-associated lipocalin in older patients with chronic kidney disease.老年慢性肾脏病患者血清中性粒细胞明胶酶相关脂质运载蛋白的评估
Aging Med (Milton). 2020 Mar 27;3(1):32-39. doi: 10.1002/agm2.12098. eCollection 2020 Mar.
3
The Associations of Blood Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin with Progression from CKD to ESRD.血肾损伤分子-1和中性粒细胞明胶酶相关脂质运载蛋白与慢性肾脏病进展至终末期肾病的关联
Clin J Am Soc Nephrol. 2016 Dec 7;11(12):2141-2149. doi: 10.2215/CJN.02670316. Epub 2016 Nov 16.
4
Use of the Kidney Failure Risk Equation to Determine the Risk of Progression to End-stage Renal Disease in Children With Chronic Kidney Disease.应用肾衰竭风险方程评估慢性肾脏病儿童进展至终末期肾病的风险。
JAMA Pediatr. 2018 Feb 1;172(2):174-180. doi: 10.1001/jamapediatrics.2017.4083.
5
Evaluation of a proteomic signature coupled with the kidney failure risk equation in predicting end stage kidney disease in a chronic kidney disease cohort.在慢性肾病队列中,评估蛋白质组学特征结合肾衰竭风险方程预测终末期肾病的情况。
Clin Proteomics. 2024 May 18;21(1):34. doi: 10.1186/s12014-024-09486-5.
6
A validation study of the kidney failure risk equation in advanced chronic kidney disease according to disease aetiology with evaluation of discrimination, calibration and clinical utility.根据病因对晚期慢性肾脏病的肾衰竭风险方程进行验证研究,评估其区分度、校准度和临床实用性。
BMC Nephrol. 2021 May 24;22(1):194. doi: 10.1186/s12882-021-02402-1.
7
External Validation of the Kidney Failure Risk Equation and Re-Calibration with Addition of Ultrasound Parameters.肾衰竭风险方程的外部验证及添加超声参数后的重新校准
Clin J Am Soc Nephrol. 2016 Apr 7;11(4):609-15. doi: 10.2215/CJN.08110715. Epub 2016 Jan 19.
8
Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease.中性粒细胞明胶酶相关脂质运载蛋白(NGAL)与慢性肾脏病的进展
Clin J Am Soc Nephrol. 2009 Feb;4(2):337-44. doi: 10.2215/CJN.03530708. Epub 2009 Jan 28.
9
Diagnostic value of neutrophil gelatinase-associated lipocalin for early diagnosis of cardiac surgery-associated acute kidney injury: a meta-analysis.中性粒细胞明胶酶相关脂质运载蛋白对心脏手术相关急性肾损伤早期诊断的价值:一项荟萃分析
Eur J Cardiothorac Surg. 2016 Mar;49(3):746-55. doi: 10.1093/ejcts/ezv199. Epub 2015 Jun 20.
10
Value of adding the renal pathological score to the kidney failure risk equation in advanced diabetic nephropathy.在晚期糖尿病肾病中,将肾脏病理评分纳入肾衰竭风险方程的价值。
PLoS One. 2018 Jan 16;13(1):e0190930. doi: 10.1371/journal.pone.0190930. eCollection 2018.

本文引用的文献

1
External Validation of the Kidney Failure Risk Equation Among Urban Community-Based Chinese Patients With CKD.中国城市社区慢性肾脏病患者肾衰竭风险方程的外部验证
Kidney Med. 2024 Mar 26;6(5):100817. doi: 10.1016/j.xkme.2024.100817. eCollection 2024 May.
2
Using the kidney failure risk equation to predict end-stage kidney disease in CKD patients of South Asian ethnicity: an external validation study.使用肾衰竭风险方程预测南亚裔慢性肾脏病患者的终末期肾病:一项外部验证研究。
Diagn Progn Res. 2023 Oct 5;7(1):22. doi: 10.1186/s41512-023-00157-x.
3
Validation of the kidney failure risk equation in predicting the risk of progression to kidney failure in a multi-ethnic Singapore chronic kidney disease cohort.
验证肾衰竭风险方程在预测新加坡多民族慢性肾脏病队列进展为肾衰竭风险中的作用。
Singapore Med J. 2022 Jun;63(6):313-318. doi: 10.11622/smedj.2020170. Epub 2020 Dec 2.
4
The Kidney Failure Risk Equation Score and CKD Care Delivery Measures: A Cross-sectional Study.肾衰竭风险方程评分与慢性肾脏病护理提供措施:一项横断面研究。
Kidney Med. 2021 Oct 15;4(1):100375. doi: 10.1016/j.xkme.2021.08.010. eCollection 2022 Jan.
5
The Effect of Age on Performance of the Kidney Failure Risk Equation in Advanced CKD.年龄对晚期慢性肾脏病肾衰竭风险方程性能的影响
Kidney Int Rep. 2021 Oct 8;6(12):2993-3001. doi: 10.1016/j.ekir.2021.09.006. eCollection 2021 Dec.
6
A validation study of the kidney failure risk equation in advanced chronic kidney disease according to disease aetiology with evaluation of discrimination, calibration and clinical utility.根据病因对晚期慢性肾脏病的肾衰竭风险方程进行验证研究,评估其区分度、校准度和临床实用性。
BMC Nephrol. 2021 May 24;22(1):194. doi: 10.1186/s12882-021-02402-1.
7
A validation study of the 4-variable and 8-variable kidney failure risk equation in transplant recipients in the United Kingdom.英国移植受者中 4 变量和 8 变量肾衰竭风险方程的验证研究。
BMC Nephrol. 2021 Feb 9;22(1):57. doi: 10.1186/s12882-021-02259-4.
8
Baseline data report of the China Dialysis Outcomes and Practice Patterns Study (DOPPS).中国透析结局和实践模式研究(DOPPS)的基线数据报告。
Sci Rep. 2021 Jan 13;11(1):873. doi: 10.1038/s41598-020-79531-4.
9
An independent validation of the kidney failure risk equation in an Asian population.亚洲人群中肾功能衰竭风险方程的独立验证。
Sci Rep. 2020 Jul 31;10(1):12920. doi: 10.1038/s41598-020-69715-3.
10
Validation of the kidney failure risk equation for end-stage kidney disease in Southeast Asia.验证东南亚终末期肾脏病风险方程对肾衰竭的预测效果。
BMC Nephrol. 2019 Dec 4;20(1):451. doi: 10.1186/s12882-019-1643-0.